TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Oslo Cancer Cluster Incubator AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,221
|
17,283
|
15,610 |
| Financial expenses |
8
|
5
|
14 |
| Earnings before taxes |
1,753
|
987
|
-393 |
| Total assets |
11,549
|
10,139
|
10,625 |
| Current assets |
9,869
|
8,572
|
9,096 |
| Current liabilities |
1,772
|
1,616
|
2,436 |
| Equity capital |
9,777
|
8,524
|
8,189 |
| - share capital |
2,252
|
2,292
|
2,455 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
84.7%
|
84.1%
|
77.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.2%
|
5.7%
|
-2.5% |
| Return on assets (ROA) |
15.2%
|
9.8%
|
-3.6% |
| Current ratio |
556.9%
|
530.4%
|
373.4% |
| Return on equity (ROE) |
17.9%
|
11.6%
|
-4.8% |
| Change turnover |
244
|
2,707
|
135 |
| Change turnover % |
1%
|
19%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.